Brief Overview of SEBIO Investor Forum 2006 Agenda:

Wednesday, November 8

Young VC Event (7:00pm-9:00pm)
Join the next generation of private equity industry leaders at this reception on the eve of day one of SEBIO. This invitation-only event is a great opportunity for emerging venture capital leaders to socialize and interact. If you are interested in attending the Young VC event, please email vcronen@informedhorizons.com.

Hospitality Suite (8:00pm-10:00pm)
The Hospitality Suite will provide an informal meeting place for those arriving on the evening of Wednesday, November 8 who want to grab a drink and a snack and network.

Thursday, November 9

Early-Stage Company Presentations and Mentoring Sessions (8:30am-2:00pm)
Each company selected for the Early-Stage Event will have the opportunity to present its "elevator pitch," PowerPoint presentation, and business plan to a specially selected Advisory Panel made up of early-stage venture capitalists, angel investors, and business and legal advisors with specifically relevant expertise.

Early-Stage Luncheon Keynote Panel (11:30am-1:00pm)
Have Money, Will Travel: Perspective of Out-of-Region Investors Financing Southeastern Companies
Some active out-of-state venture funds will discuss the success they have had investing in the Southeast region. The panel will talk about strategies for sourcing deals and share their experiences with regional companies. Speakers will discuss changes in the regional entrepreneurial community over the last decade as well as their perspective on the key strengths and issues in working with Southeastern start-ups.

Ryan Drant; General Partner, NEA

Giovanni A. Ferrara; Managing Director, Burrill & Company

Robert J. More; Partner, Domain Associates

Dr. Arnold L. Oronsky; General Partner, InterWest Partners

Timothy J. Patrick; President & CEO, Windward Medical, Inc

Early-Stage Company Workshops (1:00pm-3:00pm)

Getting to Yes: Real Tales from the Fundraising Trail

Fred Hutchison; Senior Partner, Hutchison Law Group, PLLC (Moderator)

Richard S. Kent, MD; President & CEO, Serenex, Inc

Tony Shuker; President & CEO, Metastatix

Sue Washer;President & CEO, Applied Genetic Technologies Corporation (AGTC)

Trends in Seed Investing

Brian Clevinger; Managing Director, Prolog Ventures

Lee May; Chairman, Emergent Growth Fund and Florida Angel Investment Alliance

Bruce Robertson; Managing Director, H.I.G. Ventures

Dennis Schafer; President, Life Science Management (Moderator)

Max Wallace; Arbor Group, LLC

Early Stage Company Shootout (3:00pm-4:15pm)
At the end of the four concurrent Mentoring Sessions, each Advisory Panel will select the single, best presentation and opportunity from their group and nominate that company to present its opportunity to the entire conference at the Early-Stage Shootout. A panel of celebrity judges, made up of senior venture capitalists, will assess each participant on the quality of their presentation, the viability of the venture, and the overall fundability of the opportunity. Finally, the judges will score and tabulate their assessments and select an overall winner of the competition. The four Early-Stage Shoutout finalists will be recognized during the forum.

Kick-off Reception - Georgia Aquarium (Buses depart 4:30pm)
Exclusive viewing for SEBIO attendees 5:00pm-7:00pm; Reception 5:30pm-8:00pm
The Georgia Aquarium opened on November 23, 2005 as the World's Largest Aquarium. During the advanced viewing, explore 8 million gallons of fresh and marine water containing more than 100,000 animals representing 500 species from around the globe. The Reception will be held in the Oceans Ballroom, which features a spectacular aquarium viewing window.

Friday, November 10

VC Breakfast (7:30am-8:30am)

Morning Keynote Speaker: (8:30am-9:10am)
Modernizing the FDA in the Era of Molecular Medicine

Andrew C. von Eschenbach; Acting Commissioner of the Food and Drug Administration and Former Director of the National Cancer Institute

Main Stage Company Presentations (9:10am-12:00pm)

Luncheon & Keynote Panel (12:00pm-1:30pm)
Running Faster in the Race to Cure Cancer: Developing Cancer Drugs More Quickly and Effectively
A national survey conducted by the Lance Armstrong Foundation found that "cancer" is the "greatest fear of the American people". Theirs is a reasonable fear as half of the people living in the United States in 2010 will have cancer in their lifetimes, according to the American Association of Cancer Research. What is and can be done to enhance and focus cancer research, to accelerate and streamline the regulatory process and to use the creativity, energy and resources of the private sector to take these vital drugs, devices and treatments from the lab to the American people? This panel will explore these vital questions with experts from government, academia, industry, and the investment community.

Martin Birkhofer; Vice President, Oncology Global Medical Affairs, Bristol-Myers Squibb

David H. Johnson, M.D.; Cornelius Abernathy Craig Professor, Medical and Surgical Oncology and Deputy Director, Vanderbilt-Ingram Cancer Center

Bob Ingram; Vice Chairman, Pharmaceuticals, GlaxoSmithKline

P. Sherrill Neff; Managing Partner, Quaker BioVentures, L.P.

John R. Seffrin, PhD; Chief Executive Officer, American Cancer Society

Closing Remarks and Announcement of Early-Stage Shootout Winner (1:30pm)